Healthcare Realty Trust Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Healthcare Realty Trust Inc reported revenue of $1.2B (-6.9% year on year) and net income of ($249.5M) (+62.4% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Rental income | $1.1B | $1.2B | $1.3B | $907.5M |
| Interest income | $14.3M | $16.4M | $17.1M | $11.5M |
| Other operating | $28.2M | $19.2M | $17.5M | $13.7M |
| Total Revenue | $1.2B | $1.3B | $1.3B | $932.6M |
| Property operating | $449.1M | $473.4M | $500.4M | $344.0M |
| General and administrative | $72.6M | $83.1M | $58.4M | $52.7M |
| Transaction costs | $2.0M | $3.1M | $2.0M | $3.2M |
| Merger-related costs | $0 | $0 | ($2.0M) | $103.4M |
| Depreciation and amortization | $564.0M | $675.2M | $730.7M | $453.1M |
| Total expenses | $1.1B | $1.2B | $1.3B | $956.5M |
| Gain on sales of real estate properties and other assets | $235.4M | $109.8M | $77.5M | $270.3M |
| Interest expense | ($209.0M) | $242.4M | ($258.6M) | ($146.7M) |
| (Loss) gain on extinguishment of debt | ($451.0K) | ($237.0K) | $62.0K | ($2.4M) |
| Impairment of real estate properties and credit loss reserves | ($364.6M) | ($313.5M) | ($154.9M) | — |
| Impairment of goodwill | $0 | ($250.5M) | — | — |
| Equity loss from unconsolidated joint ventures | ($188.0K) | ($135.0K) | ($1.7M) | ($687.0K) |
| Interest and other (expense) income, net | ($3.6M) | ($260.0K) | $1.3M | ($1.5M) |
| Total other income (expense) | ($342.4M) | ($697.4M) | ($336.2M) | $64.5M |
| Net loss | ($249.5M) | ($663.9M) | ($282.1M) | $40.7M |
| Net loss attributable to non-controlling interests | $3.4M | $9.4M | $3.8M | $204.0K |
| Net loss attributable to common stockholders | ($246.1M) | ($654.5M) | ($278.3M) | $40.9M |
| Basic earnings per common share (in dollars per share) | -$0.71 | -$1.81 | -$0.74 | $0.15 |
| Diluted earnings per common share (in dollars per share) | -$0.71 | -$1.81 | -$0.74 | $0.15 |
| Weighted average common shares outstanding - basic (in shares) | 349.8M | 365.6M | 378.9M | 252.4M |
| Weighted average common shares outstanding - diluted (in shares) | 349.8M | 365.6M | 378.9M | 253.9M |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Rental income | $270.6M | $267.6M | $287.4M | $287.1M |
| Interest income | $3.3M | $3.7M | $3.5M | $3.4M |
| Other operating | $8.0M | $7.7M | $6.9M | $7.0M |
| Revenues | $281.8M | $279.0M | $297.8M | $297.5M |
| Property operating | $99.0M | $100.1M | $113.5M | $109.9M |
| General and administrative | $14.4M | $17.3M | $21.8M | $23.5M |
| Transaction costs | $1.5M | $937.0K | $125.0K | $593.0K |
| Depreciation and amortization | $128.1M | $129.0M | $137.8M | $147.7M |
| Expenses | $242.9M | $247.3M | $273.2M | $281.7M |
| Gain on sales of real estate properties and other assets | $3.7M | $10.8M | $76.8M | $20.0M |
| Interest expense | ($45.1M) | ($43.9M) | ($52.6M) | ($53.3M) |
| Loss on extinguishment of debt | ($1.7M) | ($21.0K) | ($286.0K) | — |
| Impairment of real estate properties and credit loss recoveries (reserves) | ($42.7M) | $984.0K | ($104.4M) | ($142.3M) |
| Equity income from unconsolidated joint ventures | $2.9M | $496.0K | $287.0K | $158.0K |
| Interest and other (expense) income, net | $19.0K | $8.0K | ($2.9M) | ($366.0K) |
| Total other income (expense) | ($82.9M) | ($31.6M) | ($83.1M) | ($175.9M) |
| Net loss | ($44.0M) | $21.0K | ($58.5M) | ($160.1M) |
| Net loss attributable to non-controlling interests | $441.0K | ($77.0K) | $806.0K | $2.3M |
| Net loss attributable to common stockholders | ($43.5M) | ($56.0K) | ($57.7M) | ($157.9M) |
| Basic earnings per common share (in dollars per share) | -$0.13 | $0.00 | -$0.17 | -$0.45 |
| Diluted earnings per common share (in dollars per share) | -$0.13 | $0.00 | -$0.17 | -$0.45 |
| Weighted average common shares outstanding - basic (in shares) | 342.3M | 347.4M | 350.0M | 349.6M |
| Weighted average common shares outstanding - diluted (in shares) | 342.3M | 347.4M | 350.0M | 349.6M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Land | $1.1B | $1.1B | $1.3B | $1.4B |
| Buildings and improvements | $8.5B | $9.7B | $10.9B | $11.3B |
| Lease intangibles | $455.3M | $664.9M | $836.3M | $960.0M |
| Personal property | $7.1M | $9.9M | $12.7M | $11.9M |
| Investment in financing receivables, net | $123.2M | $123.7M | $122.6M | $120.2M |
| Financing lease right-of-use assets | $75.1M | $77.3M | $82.2M | $83.8M |
| Construction in progress | $0 | $32.0M | $60.7M | $35.6M |
| Land held for development | $57.5M | $52.4M | $59.9M | $74.3M |
| Total real estate investments | $10.3B | $11.8B | $13.4B | $14.1B |
| Less accumulated depreciation | ($2.4B) | ($2.5B) | ($2.2B) | ($1.6B) |
| Real estate assets held for sale, net 1 | $7.9B | $9.3B | $11.2B | $12.4B |
| Cash and cash equivalents | $26.2M | $68.9M | $25.7M | $61.0M |
| Assets held for sale, net | $143.6M | $12.9M | $8.8M | $18.9M |
| Operating lease right-of-use assets | $204.9M | $261.4M | $276.0M | $337.0M |
| Investments in unconsolidated joint ventures | $453.6M | $473.1M | $311.5M | $327.2M |
| Other assets, net | $487.8M | $507.5M | $592.4M | $470.0M |
| Total assets | $9.2B | $10.7B | $12.6B | $13.8B |
| Notes and bonds payable | $3.9B | $4.7B | $5.0B | $5.4B |
| Accounts payable and accrued liabilities | $211.1M | $222.5M | $212.0M | $244.0M |
| Liabilities of properties held for sale | $15.2M | $1.3M | $295.0K | $437.0K |
| Operating lease liabilities | $162.9M | $224.5M | $229.7M | $279.9M |
| Financing lease liabilities | $73.1M | $72.3M | $74.5M | $72.9M |
| Other liabilities | $160.5M | $161.6M | $203.0M | $218.7M |
| Total liabilities | $4.5B | $5.3B | $5.7B | $6.2B |
| Redeemable non-controlling interests | $3.3M | $4.8M | $3.9M | $2.0M |
| Preferred stock, $0.01 par value; 200,000 shares authorized; none issued and outstanding | 0 | 0 | 0 | 0 |
| Common stock, $0.01 par value; 1,000,000 shares authorized; 351,603 and 350,532 shares issued and outstanding at December 31, 2025 and 2024, respectively. | 3.5M | 3.5M | 3.8M | 3.8M |
| Additional paid-in capital | $9.1B | $9.1B | $9.6B | $9.6B |
| Accumulated other comprehensive loss | ($5.2M) | ($1.2M) | ($10.7M) | $2.1M |
| Cumulative net income attributable to common stockholders | $128.2M | $374.3M | $1.0B | $1.3B |
| Cumulative dividends | ($4.6B) | ($4.3B) | ($3.8B) | ($3.3B) |
| Total stockholders’ equity | $4.6B | $5.2B | $6.8B | $7.6B |
| Non-controlling interest | $56.5M | $66.2M | $96.3M | $108.7M |
| Total equity | $4.7B | $5.3B | $6.9B | $7.7B |
| Total liabilities, redeemable non-controlling interests, and stockholders' equity | $9.2B | $10.7B | $12.6B | $13.8B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Land | $1.1B | $1.1B | $1.1B | $1.1B |
| Buildings and improvements | $8.7B | $8.5B | $8.6B | $9.2B |
| Lease intangibles | $412.1M | $424.5M | $504.3M | $567.2M |
| Personal property | $7.5M | $7.3M | $6.9M | $6.9M |
| Investment in financing receivable, net | $6.0M | $122.3M | $123.3M | $124.1M |
| Financing lease right-of-use assets | $74.3M | $74.7M | $75.5M | $76.6M |
| Land held for development | $52.9M | $57.8M | $57.2M | $49.1M |
| Total real estate properties | $10.3B | $10.3B | $10.4B | $11.2B |
| Less accumulated depreciation and amortization | ($2.6B) | ($2.5B) | ($2.4B) | ($2.5B) |
| Total real estate properties, net | $7.7B | $7.8B | $8.0B | $8.7B |
| Cash and cash equivalents | $19.0M | $26.2M | $43.3M | $25.5M |
| Assets held for sale, net | $95.9M | $123.4M | $604.7M | $358.2M |
| Operating lease right-of-use assets | $201.9M | $202.7M | $209.3M | $243.9M |
| Investments in unconsolidated joint ventures | $457.0M | $467.5M | $458.6M | $463.4M |
| Other assets, net | $482.4M | $508.5M | $533.9M | $469.9M |
| Total assets | $9.0B | $9.1B | $9.9B | $10.2B |
| Notes and bonds payable | $4.2B | $4.1B | $4.5B | $4.7B |
| Accounts payable and accrued liabilities | $159.7M | $137.7M | $173.8M | $194.1M |
| Liabilities of assets held for sale | $14.1M | $13.6M | $69.8M | $30.3M |
| Operating lease liabilities | $161.5M | $162.4M | $166.2M | $203.7M |
| Financing lease liabilities | $74.1M | $73.7M | $72.7M | $73.0M |
| Other liabilities | $151.8M | $159.9M | $146.6M | $158.7M |
| Total liabilities | $4.7B | $4.7B | $5.1B | $5.4B |
| Redeemable non-controlling interests | $3.4M | $3.3M | $4.3M | $4.3M |
| Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding | $0.00 | $0.00 | $0.00 | $0.00 |
| Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 342,720 and 351,603 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | $3427000.00 | $3465000.00 | $3516000.00 | $3516000.00 |
| Additional paid-in capital | $8.9B | $9.0B | $9.1B | $9.1B |
| Accumulated other comprehensive income (loss) | $1.6M | ($2.4M) | ($6.5M) | ($9.2M) |
| Cumulative net income attributable to common stockholders | $84.7M | $128.2M | $113.8M | $171.6M |
| Cumulative dividends | ($4.8B) | ($4.7B) | ($4.6B) | ($4.5B) |
| Total stockholders' equity | $4.2B | $4.4B | $4.7B | $4.8B |
| Non-controlling interest | $52.4M | $54.5M | $57.6M | $59.8M |
| Total equity | $4.3B | $4.5B | $4.7B | $4.9B |
| Total liabilities, redeemable non-controlling interests, and stockholders' equity | $9.0B | $9.1B | $9.9B | $10.2B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net loss | ($249.5M) | ($663.9M) | ($282.1M) | $40.7M |
| Depreciation and amortization | $564.0M | $675.2M | $730.7M | $453.1M |
| Other amortization | $47.2M | $47.2M | $45.2M | $24.7M |
| Share-based compensation | $22.4M | $31.8M | $14.3M | $20.3M |
| Amortization of straight-line rent receivable (lessor) | ($27.1M) | ($30.0M) | ($38.7M) | ($23.5M) |
| Amortization of straight-line rent on operating leases (lessee) | $3.4M | $3.9M | $6.1M | $3.4M |
| Loss on derivatives | $4.3M | — | — | — |
| Gain on sales of real estate properties and other assets | ($235.4M) | ($109.8M) | — | — |
| Loss (gain) on extinguishment of debt | $451.0K | $237.0K | ($62.0K) | — |
| Impairment of real estate properties and credit loss reserves | $364.6M | $313.5M | $154.9M | $54.4M |
| Impairment of goodwill | $0 | $250.5M | — | — |
| Equity loss from unconsolidated joint ventures | $188.0K | $135.0K | $1.7M | $687.0K |
| Distributions from unconsolidated joint ventures | $21.5M | $10.5M | $17.9M | $1.9M |
| Non-cash interest from financing and real estate notes receivable | ($1.1M) | ($1.8M) | ($1.7M) | ($2.3M) |
| Other assets, including right-of-use-assets | ($31.5M) | ($34.5M) | ($55.9M) | ($26.1M) |
| Accounts payable and accrued liabilities | ($25.5M) | $5.2M | ($18.8M) | $24.2M |
| Other liabilities | ($828.0K) | $3.5M | $3.8M | ($30.9M) |
| Net cash provided by operating activities | $457.1M | $501.6M | $499.8M | $272.7M |
| Acquisitions of real estate | ($100.0K) | $0 | ($49.2M) | ($402.5M) |
| Development of real estate | ($12.6M) | ($70.3M) | ($41.1M) | ($37.9M) |
| Additional long-lived assets | ($330.2M) | ($249.0M) | ($231.0M) | ($163.5M) |
| Funding of mortgages and notes receivable | ($8.5M) | ($5.5M) | ($26.8M) | ($23.3M) |
| Investments in unconsolidated joint ventures | ($2.2M) | $0 | ($3.8M) | ($100.0M) |
| Investment in financing receivable | ($502.0K) | ($511.0K) | ($1.8M) | ($1.0M) |
| Proceeds from sales of real estate properties and additional long-lived assets | $1.0B | $1.2B | $701.4M | $1.2B |
| Contributions from redeemable non-controlling interests | $0 | $13.0K | $1.4M | — |
| Proceeds from insurance recovery | $2.0M | — | — | — |
| Proceeds from notes receivable repayments | $58.3M | $5.2M | $0 | $1.7M |
| Net cash provided by investing activities | $710.8M | $900.9M | $349.1M | $1.6B |
| Borrowings on unsecured credit facility | $1.4B | $0 | ($385.0M) | $40.0M |
| Repayments on unsecured credit facility | ($1.3B) | — | — | — |
| Repayment on term loans | ($650.1M) | ($350.0M) | $0 | ($1.1B) |
| Repayments of notes and bonds payable | ($266.4M) | ($25.5M) | ($19.1M) | ($20.0M) |
| Dividends paid | ($386.9M) | ($457.9M) | ($472.2M) | ($283.7M) |
| Net proceeds from issuance of common stock | $0 | $104.0K | $130.0K | $22.9M |
| Common stock redemptions | ($4.0M) | ($8.9M) | ($2.3M) | ($3.2M) |
| Common stock repurchases | $0 | ($510.4M) | — | — |
| Distributions to non-controlling interest holders | ($4.9M) | ($5.5M) | ($5.1M) | ($1.7M) |
| Redemption of non-controlling interest | ($834.0K) | ($744.0K) | — | — |
| Settlement of interest rate swaps | ($4.3M) | — | — | $0 |
| Debt issuance and assumption costs | ($13.1M) | ($563.0K) | ($529.0K) | ($12.8M) |
| Payments made on finance leases | ($53.0K) | ($17.0K) | ($17.0K) | $0 |
| Net cash used in financing activities | ($1.2B) | ($1.4B) | ($884.2M) | ($1.9B) |
| (Decrease) increase in cash and cash equivalents | ($42.7M) | $43.2M | ($35.3M) | $47.8M |
| Cash and cash equivalents cash at beginning of period | $68.9M | $25.7M | $61.0M | $13.2M |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net loss | ($43.9M) | $21.0K | ($264.1M) | ($205.5M) |
| Depreciation and amortization | $257.1M | $129.0M | $436.6M | $298.7M |
| Other amortization | $23.4M | $11.8M | $35.5M | $23.9M |
| Share-based compensation | $9.8M | $5.4M | $19.0M | $11.8M |
| Amortization of straight-line rent receivable (lessor) | ($19.7M) | ($8.5M) | ($22.4M) | ($15.6M) |
| Amortization of straight-line rent on operating leases (lessee) | $881.0K | $563.0K | $2.6M | $1.7M |
| Gain on sales of real estate properties and other assets | ($14.5M) | ($10.8M) | ($99.7M) | ($22.9M) |
| Loss on extinguishment of debt | $1.7M | $21.0K | $286.0K | — |
| Impairment of real estate properties and credit loss reserves | $41.8M | ($984.0K) | $258.8M | $154.4M |
| Equity income from unconsolidated joint ventures | ($3.4M) | ($496.0K) | ($446.0K) | ($159.0K) |
| Distributions of earnings from unconsolidated joint ventures | $10.3M | $5.3M | $16.5M | $10.8M |
| Non-cash interest from financing and notes receivable | ($818.0K) | ($428.0K) | ($657.0K) | ($395.0K) |
| Other assets, including right-of-use-assets | ($30.5M) | ($21.1M) | ($26.0M) | ($17.1M) |
| Accounts payable and accrued liabilities | ($25.9M) | ($55.5M) | ($33.0M) | ($31.1M) |
| Other liabilities | ($11.0M) | ($1.4M) | ($1.1M) | $2.4M |
| Net cash provided by operating activities | $195.1M | $52.9M | $324.8M | $211.0M |
| Acquisitions of real estate | ($6.6M) | ($2.1M) | — | — |
| Development of real estate | $0 | $0 | ($12.6M) | ($8.2M) |
| Additional long-lived assets | ($130.9M) | ($61.2M) | ($243.6M) | ($154.8M) |
| Funding of mortgages and notes receivable | ($1.6M) | — | ($6.0M) | ($2.8M) |
| Investments in unconsolidated joint ventures | ($19.0M) | ($18.6M) | ($1.5M) | ($978.0K) |
| Investment in financing receivable | $492.0K | $1.0M | ($497.0K) | — |
| Proceeds from sales of real estate properties and additional long-lived assets | $43.8M | $29.3M | $393.1M | $69.8M |
| Distributions in excess of earnings from unconsolidated joint ventures | $8.8M | — | — | — |
| Proceeds from insurance recoveries | $6.1M | $4.9M | $2.0M | $2.0M |
| Proceeds from notes receivable repayments | $46.7M | $1.3M | $53.5M | $53.2M |
| Net cash used in investing activities | ($52.3M) | ($45.3M) | $184.3M | ($41.9M) |
| Borrowings on unsecured credit facility | $265.5M | $252.0M | $831.0M | $295.0M |
| Repayments on unsecured credit facility | ($385.5M) | ($316.5M) | ($682.0M) | — |
| Net borrowings on commercial paper program | $275.5M | $250.7M | — | — |
| Repayment on term loans | $0 | $0 | ($108.5M) | ($35.1M) |
| Borrowings of notes and bonds payable | $700.0M | — | — | — |
| Redemption and repayments of notes and bonds payable | ($605.7M) | ($5.5M) | ($251.0M) | ($250.7M) |
| Dividends paid | ($166.1M) | ($83.9M) | ($302.5M) | ($217.8M) |
| Common stock redemptions | ($2.8M) | ($2.0M) | ($3.6M) | ($713.0K) |
| Common stock repurchases | ($175.0M) | ($100.0M) | $0 | $0 |
| Payments made for capped call premiums | ($28.9M) | — | — | — |
| Distributions to non-controlling interest holders | ($2.1M) | ($1.1M) | ($3.9M) | ($2.7M) |
| Redemption of non-controlling interest | ($1.0M) | ($769.0K) | ($677.0K) | ($330.0K) |
| Debt issuance and assumption costs | ($23.7M) | ($425.0K) | ($13.1M) | $0 |
| Payments made on finance leases | ($42.0K) | ($24.0K) | ($145.0K) | ($46.0K) |
| Net cash used in financing activities | ($149.9M) | ($7.5M) | ($534.5M) | ($212.3M) |
| Increase (decrease) in cash and cash equivalents | ($7.2M) | $63.0K | ($25.4M) | ($43.3M) |
| Cash and cash equivalents cash at beginning of period | $26.2M | $26.2M | $68.9M | $68.9M |
| Cash and cash equivalents at end of period, including held for sale | $19.0M | — | $43.5M | $25.7M |
Healthcare Realty Trust Inc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.